32248400|t|Pharmacological Characterization of a Betaine/GABA Transporter 1 (BGT1) Inhibitor Displaying an Unusual Biphasic Inhibition Profile and Anti-seizure Effects.
32248400|a|Focal epileptic seizures can in some patients be managed by inhibiting gamma-aminobutyric acid (GABA) uptake via the GABA transporter 1 (GAT1) using tiagabine (Gabitril ). Synergistic anti-seizure effects achieved by inhibition of both GAT1 and the betaine/GABA transporter (BGT1) by tiagabine and EF1502, compared to tiagabine alone, suggest BGT1 as a target in epilepsy. Yet, selective BGT1 inhibitors are needed for validation of this hypothesis. In that search, a series of BGT1 inhibitors typified by (1R,2S)-2-((4,4-bis(3-methylthiophen-2-yl)but-3-en-yl)(methyl)amino)cyclohexanecarboxylic acid (SBV2-114) was developed. A thorough pharmacological characterization of SBV2-114 using a cell-based [3H]GABA uptake assay at heterologously expressed BGT1, revealed an elusive biphasic inhibition profile with two IC50 values (4.7 and 556 muM). The biphasic profile was common for this structural class of compounds, including EF1502, and was confirmed in the MDCK II cell line endogenously expressing BGT1. The possibility of two binding sites for SBV2-114 at BGT1 was assessed by computational docking studies and examined by mutational studies. These investigations confirmed that the conserved residue Q299 in BGT1 is involved in, but not solely responsible for the biphasic inhibition profile of SBV2-114. Animal studies revealed anti-seizure effects of SBV2-114 in two mouse models, supporting a function of BGT1 in epilepsy. However, as SBV2-114 is apparent to be rather non-selective for BGT1, the translational relevance of this observation is unknown. Nevertheless, SBV2-114 constitutes a valuable tool compound to study the molecular mechanism of an emerging biphasic profile of BGT1-mediated GABA transport and the putative involvement of two binding sites for this class of compounds.
32248400	38	64	Betaine/GABA Transporter 1	Gene	6539;6529
32248400	66	70	BGT1	Gene	6539
32248400	141	148	seizure	Disease	MESH:D012640
32248400	164	182	epileptic seizures	Disease	MESH:D004827
32248400	195	203	patients	Species	9606
32248400	229	252	gamma-aminobutyric acid	Chemical	MESH:D005680
32248400	254	258	GABA	Chemical	MESH:D005680
32248400	275	293	GABA transporter 1	Gene	6529
32248400	295	299	GAT1	Gene	6529
32248400	307	316	tiagabine	Chemical	MESH:D000078308
32248400	318	326	Gabitril	Chemical	MESH:D000078308
32248400	347	354	seizure	Disease	MESH:D012640
32248400	394	398	GAT1	Gene	6529
32248400	433	437	BGT1	Gene	6539
32248400	442	451	tiagabine	Chemical	MESH:D000078308
32248400	456	462	EF1502	Chemical	MESH:C510806
32248400	476	485	tiagabine	Chemical	MESH:D000078308
32248400	501	505	BGT1	Gene	6539
32248400	521	529	epilepsy	Disease	MESH:D004827
32248400	546	550	BGT1	Gene	6539
32248400	636	640	BGT1	Gene	6539
32248400	664	758	(1R,2S)-2-((4,4-bis(3-methylthiophen-2-yl)but-3-en-yl)(methyl)amino)cyclohexanecarboxylic acid	Chemical	-
32248400	760	768	SBV2-114	Chemical	-
32248400	832	840	SBV2-114	Chemical	-
32248400	860	868	[3H]GABA	Chemical	-
32248400	910	914	BGT1	Gene	14411
32248400	1086	1092	EF1502	Chemical	MESH:C510806
32248400	1119	1126	MDCK II	CellLine	CVCL:0424
32248400	1161	1165	BGT1	Gene	404013
32248400	1208	1216	SBV2-114	Chemical	-
32248400	1220	1224	BGT1	Gene	6539
32248400	1373	1377	BGT1	Gene	6539
32248400	1460	1468	SBV2-114	Chemical	-
32248400	1499	1506	seizure	Disease	MESH:D012640
32248400	1518	1526	SBV2-114	Chemical	-
32248400	1534	1539	mouse	Species	10090
32248400	1573	1577	BGT1	Gene	14411
32248400	1581	1589	epilepsy	Disease	MESH:D004827
32248400	1603	1611	SBV2-114	Chemical	-
32248400	1655	1659	BGT1	Gene	14411
32248400	1735	1743	SBV2-114	Chemical	-
32248400	1849	1853	BGT1	Gene	6539
32248400	1863	1867	GABA	Chemical	MESH:D005680
32248400	Negative_Correlation	MESH:C510806	6529
32248400	Association	MESH:D005680	6529
32248400	Negative_Correlation	MESH:D000078308	6539
32248400	Association	MESH:D004827	14411
32248400	Negative_Correlation	MESH:D000078308	MESH:D012640
32248400	Negative_Correlation	MESH:D000078308	MESH:D004827
32248400	Negative_Correlation	MESH:D000078308	6529
32248400	Cotreatment	MESH:C510806	MESH:D000078308
32248400	Association	MESH:D012640	6539
32248400	Association	MESH:D004827	6539
32248400	Negative_Correlation	MESH:C510806	6539
32248400	Negative_Correlation	MESH:D000078308	MESH:D005680
32248400	Association	MESH:D012640	6529
32248400	Negative_Correlation	MESH:C510806	MESH:D012640
32248400	Association	MESH:D005680	MESH:D004827

